Resources

img

Frontiers

Cost-effectiveness analysis of implementing polygenic risk score in a workplace cardiovascular disease prevention program

Read more
Publication
img

Circulation

Risk of Coronary Artery Disease Conferred by Low-Density Lipoprotein Cholesterol Depends on Polygenic Background

Read more
Publication
img

Journal of the American Heart Association

Integrating a Polygenic Risk Score for Coronary Artery Disease as a RiskEnhancing Factor in the Pooled Cohort Equation: A Cost-Effectiveness Analysis Study

Read more
Publication
img

Nature

Mapping the human genetic architecture of COVID-19

Read more
Publication
img

Revolutionizing Cardiovascular Health in the Workplace: The Power of Preventive Genomics

See the webinar
Webinar
img

Guidance for the Clinical Implementation of Polygenic Risk Score Testing for Common Disease

See the webinar
Webinar
img

Polygenic Risk Scores the Future of Precision Medicine Challenges and Opportunities

See the webinar
Webinar
img

Polygenic Risk Scores for All

See the webinar
Webinar
img

Polygenic Risk Scores in Clinical Care Filling the Gap in Risk Assessments for Common Diseases

See the webinar
Webinar
img

Clinical Application of Polygenic Risk Scores

See the webinar
Webinar
img

Allelica White Paper: PRS for Coronary Artery Disease

Development and Validation of a Polygenic Risk Score for Coronary Artery Disease

Read more
White Paper
img

bioRxiv

Software as a Service for the Genomic Prediction of Complex Diseases

Read more
White Paper
img

medRxiv

Genetic assessments of breast cancer risk that do not account for polygenic background are incomplete and lead to incorrect preventative strategies

Read more
White Paper
img

Allelica White Paper: Multi Ancestry PRS for Coronary Artery Disease

Development and Validation of Multi-Ancestry Polygenic Risk Scores for Coronary Artery Disease

Read more
White Paper
img

Allelica Clinical Use Case Coronary Artery Disease PRS

This document outlines an approach for using a Polygenic Risk Score (PRS) in a Coronary Artery Disease (CAD) clinical pathway.

Read more
Use Case
img

Polygenic Risk Score for Breast Cancer: a Clinical Use Case

This document outlines an approach for using a Polygenic Risk Score (PRS) in a breast cancer clinical pathway.

Read more
Use Case
img

Allelica - Introduction to Polygenic Risk Score

Allelica - Introduction to Polygenic Risk Score

Watch the video
Video
img

The PREDICT Module

The PREDICT module equips genetics laboratories with a trusted software as a medical device for ancestry-informed PRS analysis and clinical-grade reporting.

Watch the video
Video
img

Leveraging Genomics to Empower the Future of the NHS: Aligning with the Darzi Review’s Vision

Lord Darzi’s Independent investigation of the NHS in England

Read more
Blog posts
img

Polygenic risk scores for breast cancer prevention: a guide for physicians

A how-to guide for how to use breast cancer polygenic risk scores

Read more
Blog posts
img

Harnessing polygenic risk scores for cardiovascular disease prevention: A guide for physicians

Atherosclerotic Cardiovascular disease (ASCVD) remains the leading cause of morbidity and mortality worldwide.

Read more
Blog posts
img

Allelica’s ancestry first approach for clinical PRS implementation

Polygenic Risk Scores (PRS) are a powerful tool in precision medicine, offering insights into an individual’s genetic predisposition to various diseases.

Read more
Blog posts
img

How to apply polygenic risk scores across diverse populations

Polygenic risk scores (PRS) predict the likelihood of developing complex diseases based on an individual’s genetic makeup. However, their application across different genetic ancestries presents numerous challenges.

Read more
Blog posts
img

What is a polygenic risk score?

Allelica builds software that enables clinical genetics labs and health systems to deploy robust and accurate Polygenic Risk Scores (PRS), at scale. But what is a PRS?

Read more
Blog posts
img

Estimating absolute risk of disease with PRSs

Allelica, Inc’s risk reports align with disease specific guidelines to communicate an individual’s risk of disease based on their PRS. Risk can be communicated as relative or absolute...

Read more
Blog posts
img

Save time and money on your clinical trials

Randomized clinical trials are the gold standard approach for testing the efficacy and safety of novel therapeutics in real world populations and are essential for bringing drugs safely to market. However, a number of variables make clinical trials...

Read more
Blog posts
img

Allelica and Labcorp collaborate for multi-ancestry polygenic risk score analysis

As Allelica continues to work toward enhancing accessible data-driven healthcare, we are proud to announce a collaboration with Labcorp to ensure polygenic and monogenic risk factors are assessed and accounted for in the patient journey...

Read more
Blog posts
img

Doctors: Don’t let high risk patients leave your office

The publication of the updated Global Burden of Disease (GBD) Reports is a timely reminder of the many different diseases that affect the global population. With somewhat morbid curiosity, it’s fascinating to...

Read more
Blog posts
img

Implementing polygenic risk scores in the clinic: Use cases for cardiovascular disease risk management

The evidence is undeniable — polygenic risk score (PRS) testing enables healthcare providers to identify more high risk patients at an earlier stage, leading to better risk management and improved outcomes...

Read more
Blog posts
img

Using polygenic risk scores to identify people who respond better to drugs

We have previously reported how polygenic risk scores (PRS) can be used to identify people at high genetic risk of disease, paving the way for their use as tools for the prevention of common, chronic disease...

Read more
Blog posts
img

It is time for polygenic risk scores to be used in breast cancer risk assessments

Much of the development of polygenic risk scores (PRSs) centers on assessing their ability to predict risk in different populations. This undoubtedly provides assurance of their clinical validity, which is a crucial component of PRS development...

Read more
Blog posts
img

The IMPUTE Module: Enriching Low-Coverage and Microarray data

Fast and scalable genome imputation of Low-Coverage WGS and Microarray data in just minutes. Allelica’s PRS pipeline is built around a set of interconnected modules…

Read more
Blog posts
img

Building the environment for genetic risk prediction for cardiovascular disease

Bringing a new medical test to market requires generating and compiling a range of evidence. A commonly used framework for evaluating novel genetic tests involves describing an assessment of three main aspects of the test: its analytical validity,...

Read more
Blog posts
img

Cardiovascular disease in the workplace: how to leverage data-driven solutions to the biggest health challenge facing employers

In today’s fast-paced corporate landscape, the health and well-being of employees are paramount for sustained productivity and success. One of the most prevalent health challenges facing workplaces is cardiovascular disease, particularly...

Read more
Blog posts
img

Five Considerations for Selecting a Workplace Wellness Program: How to Achieve Strong ROI for Employers & Long-Term Benefits for Employees

In the fast-paced world of business, ensuring the well-being of employees has become a top priority for innovative employers. A successful wellness program not only fosters a culture of healthier and happier employees, but also yields impressive returns...

Read more
Blog posts
img

How to ensure lasting employee engagement in your workplace health program

Maintaining a healthy and engaged workforce is a cornerstone of a successful organization. Workplace health programs not only enhance the well-being of employees but also contribute to increased productivity, reduced absenteeism, and...

Read more
Blog posts
img

Using polygenic risk scores to enhance cardiovascular disease risk prediction

Cardiovascular diseases — a general term for a suite of diseases that affect the heart or blood vessels — account for one in three deaths globally and are a major drain on public health spending. Our risk of cardiovascular disease increases as we age...

Read more
Blog posts
img

How to superpower a clinical trial with PRS

Clinical trials are an essential part of the pharmaceutical industry, but they face many challenges. One of the significant obstacles is the high rate of failure, with over 90% of drug candidates that...

Read more
Blog posts
img

PRS & Shared Decision Making

A valid question that is often asked when discussing PRS implementation is “how will this information be used in clinical care in the absence of clinical guidelines for PRS”? One approach is to ensure PRS risk information is presented in a way that...

Read more
Blog posts
img

NSGC’s PRS Practice Resource: Your PRS one-stop shop

This year was kicked off by the publication of the NSGC Practice Resource for Clinical Counseling/Translation of Polygenic Scores, put together by Wand et al. — a stellar team of leaders in the PRS field.

Read more
Blog posts
img

PRS-powered disease risk reporting

We’ve previously written about how you can use Allelica’s DISCOVER software to build new polygenic risk scores (PRS) and to deploy them at scale with PREDICT. While a PRS provides…

Read more
Blog posts
img

Harnessing the power of PRS by combining standardized reporting with Allelica’s software

This week, scientists from the Clinical Genome Resource (ClinGen) Complex Disease Working Group and the Polygenic Score (PGS) Catalog published a paper in Nature introducing…

Read more
Blog posts
img

Understanding the link between genetics, cholesterol and coronary artery disease

Cardiovascular disease is the leading cause of death worldwide, with recent estimates putting the global death toll at around 18 million each year. It is also a major burden on populations and health systems, contributing to…

Read more
Blog posts
img

The PREDICT Module: Unlocking the power of genomics

In our previous articles on Allelica’s PRS pipeline, we ran through how you can use our DISCOVER module to build your own PRS for a disease or trait of interest, as well as how our VALIDATE module can be used to test the predictive power of…

Read more
Blog posts
img

The VALIDATE module: Quantifying the power of PRS

Essential testing of your PRS on an independent population. In our previous articles outlining Allelica’s PRS pipeline we described how users can impute genotype or…

Read more
Blog posts
img

The DISCOVER Module: Seamlessly building new polygenic risk scores

A user friendly, cloud-based computing solution to build state-of-the-art, publication ready polygenic risk scores. The DISCOVER moduleallows users to build their own polygenic risk…

Read more
Blog posts
img

Coronary Artery Disease: Predicting risk through genetics

Within the last two decades, and upon completion of the world’s largest biological project in 2003, interest in the human genome and its effect on…

Read more
Blog posts
img

Large Scale Genomics Datasets In the UK

We previously wrote about the enormous impact that the UK Biobank (UKBB) is having to translational research. Although the scientific outputs from this project are now beginning…

Read more
Blog posts
img

Genetics is actionable

In Allelica we’re very excited about the incredible advances that analyses of large DNA datasets are bringing to medicine. In addition to the increasingly…

Read more
Blog posts
img

Beyond BRCA

Vast quantities of human DNA have been sequenced for biomedical research and clinicians, researchers and innovators are now beginning to focus on the next phase of the genomic revolution: translating these data into tools...

Read more
Blog posts
img

Disease is Polygenic

In the late 19th Century, a Moravian monk named Gregor Mendel passed his time by running experiments cross-breeding different types of pea plant. Amongst his…

Read more
Blog posts
img

The UK Biobank: unleashing the power of genome

A central goal of preventative medicine is to identify the people most at risk of disease early enough that something can be done…

Read more
Blog posts
img

Allelica announces the release of the Allelica Precision Server for CLIA-compliant, on-premises analysis and clinical reporting of polygenic risk score, pharmacogenomics and carrier screening

Read more
Press Release
img

Allelica, SP BioMed Partner for Breast Cancer Polygenic Risk Score Study in Taiwan

Read more
Press Release
img

UAB Cardiogenomics Clinic and Allelica to perform polygenic risk score clinical implementation study

Read more
Press Release
img

Allelica Launches Ancestry-Specific Polygenic Risk Score Tests for Common Diseases as a Laboratory-Developed Test

Read more
Press Release
img

Allelica's Health Economics Study Demonstrates Cost Savings of Polygenic Risk Score in Heart Attack Prevention

Read more
Press Release
img

Allelica Collaborates with Invitae to Build Ancestry-Informed Polygenic Risk Score for Breast Cancer

Read more
Press Release
img

Allelica Joins Forces with Leader in Genotyping Technology to Enable Polygenic Risk Score

Read more
Press Release
img

Yale School of Medicine Researcher Selects Allelica to Expand Polygenic Risk Score Research on Childhood Neuropsychiatric Disorders

Read more
Press Release
img

Allelica, the Leader in Polygenic Risk Scoring, Expands Scientific Advisory Board

Read more
Press Release
img

The University of Sydney secured a AU$1.4M grant plus AU$2M from industry and partners with Allelica, Inc. to advance heart disease prevention strategies through Polygenic Risk Score application

Read more
Press Release